 continu intra-arteri administr recombin low-stag bladder cancer phase IB studi toxic clinic effect intra-arteri IA continu infus recombin twelv patient low-stag transit cell carcinoma tcc bladder dosag group patient cours interv evalu clinic respons transurethr resect tur world health organ who toxic patient hypotension/ment confus fever side effect infus laboratori toxic patient proven complet respons CR partial respons PR patient patient overal respons rate object respons mean follow-up time month rang month local relaps month tur nonrespond